NASDAQ:XBIO | Free Cash Flow | Xenetic Biosciences, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2011-11-30 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$536,377.00
2025-12-31-$242,682.00
2025-03-31-$1M
2024-12-31-$673,992.00
2024-03-31-$1.16M
2023-12-31-$793,027.00
2023-03-31-$1.1M
2022-12-31-$750,907.00
2022-03-31-$2.09M
2021-12-31-$1.46M
2021-03-31-$1.52M
2020-12-31-$953,660.00
2020-03-31-$1M
2019-12-31-$1.68M
2019-03-31-$1.25M
2018-12-31-$1.04M$0.00-$1.04M
2018-03-31-$1.67M$0.00-$1.67M
2017-12-31$4.84M$0.00$4.84M108.84%
2017-03-31$280,809.00$5,429.00$275,380.00
2016-12-31-$4.62M$2,180.00-$4.63M
2016-03-31-$1.77M$14,613.00-$1.79M
2015-12-31-$1.12M$0.00-$1.12M
2015-03-31-$2.04M$0.00-$2.04M
2014-12-31-$2.66M$11,660.00-$2.68M
2014-03-31-$4.12M$16,992.00-$4.14M
2013-12-31-$2.01M$63,830.00-$2.07M
2013-11-30-$173,144.00$212,500.00-$385,644.00
2013-08-31$250,431.00$0.00$250,431.00
2013-03-31-$942,281.00$4,090.00-$946,371.00
2012-11-30$212,500.00
2012-08-31-$1,051.00
2011-11-30-$1,825.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$2.29M
2024-12-31-$2.82M
2023-12-31-$4.11M
2022-12-31-$4.65M
2021-12-31-$4.74M
2020-12-31-$4.27M
2019-12-31-$6.4M
2018-12-31-$6.46M$0.00-$6.46M
2017-12-31$1.49M$9,264.00$1.48M
2016-12-31-$8.79M$16,793.00-$8.8M
2015-12-31-$5.3M$1,663.00-$5.3M
2014-12-31-$12.68M$57,669.00-$12.74M
2013-12-31-$6.05M$78,634.00-$6.13M
2013-08-31$280,609.00$212,500.00$68,109.00
2012-12-31-$6.26M$130,084.00-$6.39M
2012-08-31-$12,995.00

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.